OBJECTIVE: To Produce gentamycin sulfate sustained-release tablets.
目的:制备硫酸庆大霉素缓释片。
Objective To obtain an average safe dose of Fuzi Lizhong sustained-release tablets.
目的确定附子理中缓释片的安全剂量。
OBJECTIVE To prepare oxymatrine sustained-release tablets and evaluate the drag release property.
目的制备氧化苦参碱缓释片剂,并评价其体外释药特性。
OBJECTIVE To prepare vitamin C sustained-release tablets and determine their in vitro release rate.
目的:研制维生素c微囊并制成缓释片剂,评价其体外释放特性。
CONCLUSION With the reasonable formulation, the sustained-release tablets reach the expected level.
结论该缓释片处方合理,达到了预期结果。
ObjectiveTo prepare potassium citrate sustained-release tablets and study its in-vitro release mechanism.
目的制备枸橼酸钾缓释片并考查其体外释放机制。
Objective To obtain effective materials from the total alkaloids of Fuzi Lizhong sustained-release tablets.
目的分析附子理中缓释片中总生物碱的药效物质。
CONCLUSION the sustained-release tablets reach the expectable results with its reasonable formulation and simple technology.
结论该缓释片处方合理,制备工艺简单,达到了预期结果。
Objective to study on the factors involved in the release rate of metformin hydrochloride in vitro sustained-release tablets.
目的对盐酸二甲双胍缓释片体外释放度相关因素进行研究。
Patients in control group were given Theophylline sustained-release tablets, and Salbutamol Aerosol according to circumstances;
对照组予以茶碱缓释片口服,并酌情给予沙丁胺醇气雾剂治疗;
CONCLUSION The sustained-release and colon-specific characteristics of metronidazole colon-specific sustained-release tablets were obvious.
结论甲硝唑结肠缓释片具有结肠靶向和缓释的特征。
Conclusion This method is reliable and simple which could be used for the quality control of compound ferrous sulfate sustained-release tablets.
结论方法可靠,简单可行,可用于复方硫酸亚铁缓释片的质量控制。
Objective to establish a UV method to determine the release degree of rotundine sustained-release tablets and to evaluate its in-vitro release behavior.
目的建立罗通定缓释片体外释放度测定方法,评价其体外释药行为。
In the present study, silymarin sustained-release tablets were developed to delay the drug release, reduce dosing frequency and improve patient compliance.
本文研制了水飞蓟素缓释片,以延缓药物的释放,减少给药次数,提高患者的顺应性。
OBJECTIVE A reversed phase HPLC method was developed to determine the contents of metoprolol tartrate and felodipine in compound felodipine sustained-release tablets.
目的对复方非洛地平缓释片中酒石酸美托洛尔和非洛地平的含量测定方法进行研究。
The phase transition, barrier function and front movement of the gel layer are closely related to drug release process of hydrophlic gel matrix sustained-release tablets.
亲水凝胶骨架缓释片的释药过程与相转变过程、凝胶层屏障及区域前沿移动行为密切相关。
The results indicated that the sustained-release tablets had an expected sustained-release quality, and drug release pattern was in accorded with the first order kinetics.
结果表明,制得的酒石酸美托洛尔缓释片具有明显的缓释作用,体外释放符合一级释药动力学规律。
Conclusions the determination method is simple and swift, and can be applied in the determination of in vitro release rate of metformin hydrochloride sustained-release tablets.
结论本释放度方法简单,快速,可用于盐酸二甲双胍缓释片体外释放度测定。
Conclusion: Both captopril sustained-release tablets and valsartan are effective, and the combining use of the two drugs is effective on refractory hypertension in uremia patients.
结论:缬沙坦、卡托普利缓释片是治疗高血压的有效药物,二者联合应用是治疗尿毒症顽固性高血压的较好方法。
OBJECTIVE Breviscapine sustained-release tablets(BST)were formulated with hydroxypropyl-methylcellulose as the matrix material and the release mechanism of the tablets was studied.
目的以羟丙甲基纤维素为骨架材料制得灯盏花素缓释片,并对释药机制进行探讨。
Methods Ultraviolet spectrophotometry and release test were applied to determine the release of cefixime in cefixime sustained-release tablets under different media and time points.
方法用紫外分光光度法和释放度试验,考察头孢克肟缓释片在不同释放介质中不同释放时间的累积释放度。
Method: GBE sustained-release tablets were prepared by direct compression method using sodium carboxymethylcellulose CMC-Na and hydroxypropyl methylcellulose HPMC as matrix excipients.
方法:以溶胀性材料羧甲基纤维素钠和羟丙甲基纤维素为骨架材料,直接粉末压片制备银杏提取物缓释片。
The control group was treated with Nifedipine Sustained-release Tablets, Benaaepril Hydrochleride Tablets.
对照组给予硝苯地平缓释片、盐酸贝那普利片等治疗。
Objective: to develop the methods to determine the in vitro release of multi-target ingredients in Compound Danshen Sustained-release Tablets and to evaluate its release behavior in vitro.
目的:建立复方丹参缓释片多指标成分的体外释放度测定方法,评价其体外释药行为。
Objective To use ANN to quantitatively predict the influence of the amount of HPMC and its internal viscosity on allopurinol release from HPMC sustained release tablets.
目的用人工神经网络模型定量的预测HPMC的量和其固有黏度对药物释放的影响。
Objective to manufacture Amoxicillin into gastric floating sustained release tablets, which can extend their stay time in stomach to make Amoxicillin release slowly and to increase bioavailability.
目的将阿莫西林制成胃漂浮缓释片,延长在胃中的停留时间,逐渐释放,提高生物利用度。
Objective To prepare and optimize the formulation of buflomedil hydrochloride sustained release tablets.
目的应用定制设计法优化盐酸丁咯地尔缓释片的处方。
OBJECTIVE: to prepare the sustained release tablets of salbutamol sulfate, and to establish the method of quality control.
目的:制备硫酸沙丁胺醇延迟释药片,并建立其质量控制方法。
The results indicated that the sustained release tablets had an expected sustained release quality, and the drug release pattern was in accorded with the first order kinetics.
结果表明:研制缓释片的缓释效果良好,药物的释放符合一级动力学规律。
Conclusions Ibuprofen sustained release tablets with ideal release behavior could be prepared by selecting HPMC with different viscosity and adjusting the content of HPMC.
结论联合应用不同黏度和用量的HPMC,可制备具有理想释药行为的布洛芬骨架缓释片。
应用推荐